Excessive expansion of white adipose tissue leads to
hypoxia which is considered as a key factor responsible for adipose tissue dysfunction in
obesity.
Hypoxia induces
inflammation,
insulin resistance, and other
obesity related complications. So the
hypoxia-signalling pathway is expected to provide a new target for the treatment of
obesity-associated complications. Inhibition or downregulation of the HIF-1 pathway could be an effective target for the treatment of
obesity related
hypoxia. In the present study, we evaluated the effect of
hypoxia on functions of 3T3-L1 adipocytes emphasising on oxidative stress,
antioxidant status,
inflammation and mitochondrial functions. We have also evaluated the protective role of
bilobalide, a bioactive from Gingko biloba, on
hypoxia induced alterations. The results revealed that
hypoxia significantly altered all the vital parameters of adipocyte biology like HIF-1α expression (103.47% ↑),
lactate and
glycerol release (184.34% and 69.1% ↑, respectively),
reactive oxygen species (ROS) production (432.53% ↑),
lipid and
protein oxidation (376.6% and 566.6% ↑, respectively), reduction in
antioxidant enzymes (
superoxide dismutase and
catalase) status, secretion of inflammatory markers (TNF-α, IL-6, IL-1β and IFN-γ) and mitochondrial functions (mitochondrial mass, membrane potential, permeability transition pore integrity,
superoxide generation).
Bilobalide significantly protected adipocytes from adverse effects of
hypoxia in a dose-dependent manner by attenuating oxidative stress,
inflammation and protecting mitochondria.
Acriflavine (HIF-1 inhibitor) was used as positive control. On the basis of this study, a detailed investigation is needed to delineate the mechanism of action of
bilobalide to develop it as therapeutic target for
obesity.